Skip to content
Screener

Common Stock at other companies

Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
2B0.0%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
400M0.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$821.24M+3.7%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$29K-3.3%
Assembly Biosciences logo
Assembly BiosciencesASMB
$16K+100%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
200M0.0%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.41B+235%
Enterprise value$1.4B+279%
P/S765.8×+664×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:24 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001672688-26-000088
(In thousands, except for share and per share data)March 31, 2026December 31, 2025
TOTAL LIABILITIES23,62226,848
STOCKHOLDERS' EQUITY
Preferred stock
Common stock1515
Additional paid-in capital826,035813,627
Accumulated deficit(654,383)(624,784)
Accumulated other comprehensive income304591
TOTAL STOCKHOLDERS' EQUITY171,971189,449

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's common stock?
Absci Corporation (ABSI) reported common stock of $15K in Q1 2026.
How has Absci Corporation's common stock changed year-over-year?
Absci Corporation's common stock increased by 15.4% year-over-year, from $13K to $15K.
What is the long-term trend for Absci Corporation's common stock?
Over 5 years (2020 to 2025), Absci Corporation's common stock has grown at a 49.6% compound annual growth rate (CAGR), from $2K to $15K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Absci Corporation's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude